Featured Research

from universities, journals, and other organizations

Weekly Dose Of Osteoporosis Drug Prevents Bone Loss After Breast Cancer Treatment

Date:
September 20, 2007
Source:
University of Pittsburgh Schools of the Health Sciences
Summary:
Breast cancer survivors who took a weekly dose of risedronate, sold as Actonel, lost significantly less bone than those who did not take the drug, according to a new two-year study. Researchers evaluated 87 women enrolled in the Prevention of Osteoporosis in Postmenopausal Women with Breast Cancer Following Chemotherapy study.

Breast cancer survivors who took a weekly dose of risedronate, sold as Actonel, lost significantly less bone than those who did not take the drug, according to a two-year study from the University of Pittsburgh School of Medicine.

Related Articles


Susan Greenspan, M.D., director of the Osteoporosis Prevention and Treatment Center and Bone Health program at the University of Pittsburgh Medical Center, and colleagues evaluated 87 women, mean age 50, enrolled in the Prevention of Osteoporosis in Postmenopausal Women with Breast Cancer Following Chemotherapy study. All participants in the randomized, double-blind trial received calcium and vitamin D supplements. However, half took 35 milligrams of risedronate once a week while others took a placebo.

"Chemotherapy drugs and other medical treatments for breast cancer are known to induce menopause, which can kick-start bone loss, putting survivors at risk for osteoporotic fractures," said Dr. Greenspan, an internationally respected osteoporosis researcher and professor of medicine at Pitt. "This study also looked at changes in spine and hip bone mineral density, as well as evidence of bone breakdown."

Ninety-seven percent of study participants had normal or low bone mass at enrollment. At baseline, many were taking tamoxifen, a breast cancer drug aimed at estrogen-sensitive tumors that also is sometimes used as a preventive therapy by women at high risk for breast cancer.

While tamoxifen can have a positive impact on bone in postmenopausal women, a small percentage of women were taking aromatase inhibitors (also used for prevention), which can have a negative effect on bone. During the second year of the study, about half the women began taking aromatase inhibitors and stopped taking tamoxifen.

"After 24 months, women in the placebo group had significant bone loss in the spine and hip that we didn't see in women taking risedronate," noted Dr. Greenspan. "In fact, women taking risedronate had a bone density much higher in the spine and hip than women in the placebo group." The researchers also observed that the greatest bone loss was found in women on aromatase inhibitors. Even so, risedronate continued to be successful in preventing bone loss.

"We conclude that once weekly doses of risedronate improves bone density and prevents excess bone loss in breast cancer survivors," the researchers noted.

This research was recently presented at the 29th annual meeting of the American Society for Bone and Mineral Research. Scientific sessions are being held at the Hawaii Convention Center.

In addition to Dr. Greenspan, other authors are Karen T. Vujevich, M.S.N., Adam Brufsky, M.D., Barry C. Lembersky, M.D., Subashan Perera, Ph.D., and Victor Vogel, M.D., University of Pittsburgh School of Medicine; and Raj Bhattacharya, M.D., University of Kansas School of Medicine.


Story Source:

The above story is based on materials provided by University of Pittsburgh Schools of the Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

University of Pittsburgh Schools of the Health Sciences. "Weekly Dose Of Osteoporosis Drug Prevents Bone Loss After Breast Cancer Treatment." ScienceDaily. ScienceDaily, 20 September 2007. <www.sciencedaily.com/releases/2007/09/070918105423.htm>.
University of Pittsburgh Schools of the Health Sciences. (2007, September 20). Weekly Dose Of Osteoporosis Drug Prevents Bone Loss After Breast Cancer Treatment. ScienceDaily. Retrieved March 28, 2015 from www.sciencedaily.com/releases/2007/09/070918105423.htm
University of Pittsburgh Schools of the Health Sciences. "Weekly Dose Of Osteoporosis Drug Prevents Bone Loss After Breast Cancer Treatment." ScienceDaily. www.sciencedaily.com/releases/2007/09/070918105423.htm (accessed March 28, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, March 28, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins